Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than...
SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”...
NESS ZIONA, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients...
- Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in...
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each...
Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes...
Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for...
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext...
Conduit Pharmaceuticals strengthens its Board of Directors with the addition of Simon Fry, a seasoned investment banking executive with over...
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- GQR Life Sciences, a leader in total talent solutions for the biopharma industry, is...
Pharma and health care industries take deliberate steps, not leaps, toward AI innovation and digital transformation CARY, N.C., Nov. 19,...
List recognizes groundbreaking advancements redefining the way we work and live. CAMBRIDGE, Mass., Nov. 19, 2024 /PRNewswire/ -- Epicore Biosystems (Epicore),...
Choosing Canada as its first market outside of Europe, Aktiia's clinically validated 'cuffless' blood monitoring bracelet is now available as the...
HALIFAX, NS, Nov. 19, 2024 /PRNewswire/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development,...
Achievement underscores expertise in cloud-driven advancements for drug discovery, genomics, clinical trials, and personalized medicine BOSTON, Nov. 19, 2024 /PRNewswire/...
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life...
Partnership announced with Chan Zuckerberg Initiative to drive rare disease drug development With its leading consumer health AI platform, Citizen...
Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for...
--Six sites across the U.S. are now engaged in Phase1b study Marlborough, Massachusetts--(Newsfile Corp. - November 19, 2024) - Phio...
WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused...